Date & Time
August 15, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
About the Event
COPD is the fourth leading cause of death in the United States, yet there is no therapy on the market to effectively treat patients with the most severe airway blockages.
Aer Therapeutics has developed Aer-01, an inhaled treatment that is literally a breath of fresh air for 5 million COPD patients. The market potential in the U.S. alone for this limited scope is $10.5B and grows as you include other related lung diseases
Join us for a live webinar with Aer President and CEO, Jim Shaffer to learn more about this unique investment opportunity.